Publications in collaboration with researchers from Queen Elizabeth Hospital (1)

2001

  1. Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression

    Urology, Vol. 58, Núm. 2, pp. 146-150